Janux Therapeutics
Jerry Warren has been in the Regulatory Affairs field since 2007. Jerry began their career at Abbott Laboratories as an Associate Director, Regulatory Affairs and held that position until 2013. Jerry then moved to AbbVie, where they held the same position until 2021. Currently, they are a Senior Director Regulatory Affairs at Janux Therapeutics.
Jerry Warren obtained a Bachelor of Science in Biochemistry and Cell Biology from Worcester Polytechnic Institute and a Master of Business Administration from Babson College. Jerry also holds certifications in RAC EU and RAC US from RAPS.
This person is not in any offices
Janux Therapeutics
1 followers
Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.